|
Pelabresib Clinical Trials
1 actively recruiting trial across 1 location
Also known as: CPI-0610
Los Angeles, California1 trial
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Hematologic Malignancy/Stem (Department of Medicine, Division of Hematology/Oncology)
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.